Trial Profile
Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C Infected Patients with Compensated and Decompensated Cirrhosis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 01 Dec 2015 New trial record